Pharmanovia A/S: Financial statements 2021
CVR: 32287824
Source: annual report 2021, Danish Business Authority
01/04/2020 – 31/03/2021
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 15,223,656 and a net result of DKK -2,028,136 compared with DKK -13,715,317 the year before. That is an increase of 308.1% compared with the year before. Equity in the 2021 report amounted to DKK 15,109,690. The solvency ratio was 54.1%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 15,223,656
- Profit/Loss
- DKK -2,028,136
- Equity
- DKK 15,109,690
- Total Assets
- DKK 27,912,356
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 15.2M | -2M | 15.1M | 15 |
| 2020 | - | 3.7M | -13.7M | 17.1M | 12 |
| 2019 | - | 10.6M | -5.9M | -19.9M | 12 |
| 2018 | - | 2.6M | -9.2M | -14M | 8 |
| 2015 | - | 1.5M | -2.2M | -12.3M | 4 |
Official annual report
Find more companies like Pharmanovia A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 17, 2021, James Charles Burt has joined the board of directors of Pharmanovia A/S.
As of December 17, 2021, Alastair Thomas Badgett Hay has left the board of directors of Pharmanovia A/S.
As of June 16, 2021, Felipe Andres Florez Arango has joined the board of directors of Pharmanovia A/S.
On June 16, 2021, the company changed its name from Atnahs Pharma Nordics A/S to Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.